>
>

Enteral Feeding Formulas Market – By Product, By Stage, By Application, By End Use – Global Forecast, 2024 – 2032

Download Free PDF

Enteral Feeding Formulas Market Size

The global enteral feeding formulas market size was valued at around USD 7 billion in 2023 and is estimated to grow at 7.1% CAGR from 2024 to 2032. Enteral feeding formulas are specifically designed liquid foods that are intended to provide nutrition to those who cannot eat by mouth because of such medical conditions as difficulty swallowing, digestive issues or certain diseases of the nervous system. They are administered through a feeding tube that passes directly to the stomach or small intestine.
 

Enteral Feeding Formulas Market

Considering the worldwide increase in the prevalence of chronic conditions like cancer, stroke, multiple sclerosis, dementia, chronic liver disease, COPD and even diabetes, it is expected that the demand for solutions for oral intake will further increase. For instance, according to forecasts by the International Diabetes Federation (IDF), there will be a significant increase in the number of diabetes adults from 537 million in 2021 to 643 million in 2030, reaching 783 million by 2045.
 

Furthermore, dietary management of sarcopenia, a condition in older adults usually characterized by diminished muscle strength, often includes enteral foods. In a study published in BioMed Central in December 2022, it was demonstrated that median prevalence of sarcopenia among older adults is 1-29%, and it is more common among people in long-term care facilities. This study established a significant correlation between malnutrition and sarcopenia, here, it was acknowledged that loss of muscle mass was very high among the malnourished individuals. Considering this, together with the demographic factors of the elderly population and increase in age-related ailments, the market is on the cusp of tremendous growth.
 

Additionally, according to the World Health Organization (WHO), the worldwide preterm birth rate sits at 5-18% of total births. This means there is a direct rise in sip feeds for newborns. Adding to that problem is the issue of lack of nutrients, especially in infants and pregnant women, along with vital micronutrient proteins and other important nutrients. This scenario highlights the shortage of all these nutritional items targeted towards new mothers and babies.

Enteral Feeding Formulas Market Trends

  • The growing demand for specialized nutrition in treating conditions like oncology and inflammatory bowel disease, with further development of newborn specialized formula sip feeds will aid in boosting the market growth.
     

  • The increased number of patients and old people who constantly need enteral feeding due to chronic incurable diseases, and after surgical procedures or critical nursing is linear with the world market increase rates. For instance, according to the World Health Organization, by 2030 one in every six people is estimated to be 60 years old and above, and the global population in this age group will rise from one billion people in 2020 to 1.4 billion. By 2050, the value is expected to double to 2.1 billion people aged 60 and above. Also, the number of people aged 80 and above is projected to reach 426 million in 2050, which will be triple the value of the same number in 2020. This indicates a strong potential for demand growth in the market of enteral nutrition solutions with the demographic shift.
     

  • The advancement of delivery systems such as smart feeding pumps and handy packaging of enteral formulas is increasing patient acceptance and making the work easier for caregivers. These improvements are likely to enhance patient results and increase the use of enteral nutrition therapies.
     

Enteral Feeding Formulas Market Analysis

Enteral Feeding Formulas Market, By Product, 2021 – 2032 (USD Billion)

The market comprises standard formulas, disease-specific formulas, elemental formulas, semi-elemental formulas, and other variants. In 2023, standard formulas led the market, generating a revenue of USD 3.6 billion, primarily due to their widespread adoption across diverse patient groups and their cost-effectiveness.
 

  • The segment is expected to grow in the next few years, driven by the easy access and cheaper prices of polymeric nutritional complete (standard) formulas for both hospital and home care use.
     
  • Additionally, physicians recommend standard formulas for gastrostomy tube (G-tube) patients for better nutrition in kids, which helps the segment grow. For instance, according to the Journal of Pediatric Gastroenterology and Nutrition, a corresponding increase in G-tube dependency in children with a prevalence rate of 84 per 100000 children in the year 2020 was recorded. This emphasizes how critical standard formulas are for meeting the nutritional needs of children who depend on G-tubes.
     
  • Given these insights, the demand for standard formulas is anticipated to remain robust in the foreseeable future.

 

Enteral Feeding Formulas Market, By Stage (2023)

Based on stage, the enteral feeding formulas market is divided into adults and pediatric segments. In 2023, adults accounted for a dominant 82.2% share of the market revenue.
 

  • The need for enteral feeding is common among older adults, and with the steady population growth globally, this sector has seen a rise in market demand. For instance, the WHO anticipates that by 2050, people over the age of 60 will be 22% of the population compared to 12% in 2015. Formulation for enteral feeding is designed for people who are unable to eat or swallow food. The changing healthcare systems to cater to the needs of the aging population will further enhance the shift in this segment of the market.
     
  • There is a growing need for enteral feeding formulas because of cancer and some neurological disorders which are common among adults and lead to disrupted normal eating habits, often leading to poor consumption of calories. In fact, The National Cancer Institute has recorded an annual incidence of 440.5 new cancer cases per 100,000 people across both genders.
     
  • This trend is expected to continue, which will result in a reliance of enteral feeding among healthcare providers and patients craving effective solutions for nutrition among chronic conditions. For cancer patients, there seems to be a growing difficulty in oral feeding which shifts the focus towards alternative nutrition.
     
  • Consequently, these factors are set to significantly propel the segment's growth in the forecast period.
     

The enteral feeding formulas market is segmented into oncology, gastrointestinal diseases, neurological disorders, diabetes, critical care, and other applications based on application. The oncology segment is projected to reach USD 3.9 billion by 2032.
 

  • The increase in the cancer population is one of the major reasons for the demand in enteral feeding formulas. Enteral feeding is a process that WHO expects to account for over 35 million new diagnoses in cancer by 2050, a 77% increase from the 20 million cases in 2022. This pronounced shift supports the idea of patient care interventions designed to improve nutritional support – specifically, enteral nutrition support among cancer patient groups.
     
  • Due to treatment side effects, oral intake for oncology patients tends to be problematic. Issues like nausea during chemotherapy, sore mouths during radiation therapy make using enteral feeding formulas preferable for nutrition.
     
  • Medical practitioners are starting to appreciate the significance of nutrition in the treatment process for cancer patients. With appropriate nutrition, treatment response, complication rates, and the general well-being of the patients can improve.
     
  • Thus, these dynamics are poised to drive the segment's growth in the foreseeable future.
     

The enteral feeding formulas market is segmented by end use into hospitals, long-term care facilities, home care settings, and nursing homes. In 2023, the hospitals segment was valued at USD 3.2 billion.
 

  • More attention is now being turned towards the importance of food as an investment in the patient health and recovery outcomes. Enteric feeding can promote wound healing, reduce complications, and improve recovery times in patients on admission.
     
  • The increasing concern for malnutrition in hospitals has increased the need for enteral feeding. Hospitals are adopting enteral feeding with screening protocols to identify at-risk patients. For instance, according to the National Institutes of Health, the number of patients suffering from malnutrition in hospitals is between 20 to 50% meaning there is a strong need for nutrition support.
     
  • Health organizations and authorities have placed greater emphasis on support for nutrition in clinical settings. The guidelines in supportive groups to further promote the use of enteral nutrition in specific patient groups are leading to these formulas being introduced into standard care in hospitals. For instance, the European Society for Clinical Nutrition and Metabolism (ESPEN) recommends starting enteral nutrition within 24-48 hours of admission to the hospital for patients who are critically ill and cannot eat anything by mouth.
     
  • Thus, the heightened focus on nutrition in healthcare, bolstered by insights from esteemed health organizations, is set to fuel the adoption and evolution of enteral nutrition solutions in hospitals.

 

U.S. Enteral Feeding Formulas Market, 2021 – 2032 (USD Billion)

In 2023, the U.S. enteral feeding formulas market was valued at USD 2.8 billion, with projections indicating a growth at a CAGR of 7.2% over the forecast period.
 

  • There is a broad range of players in the U.S. market of enteral feeding who are changing product formulations and developing innovations like lactose-free, gluten-free and low residue products. These improvements serve a wide variety of patients which further drives market growth.
     
  • One of the factors that is driving the market for enteral feeding formulas in the U.S is the aging population. An analysis conducted by the U.S. Census Bureau foresees a change in demographics with the population aged 65 and older to nearly double from 52 million in 2018 to an estimated 95 million by 2060. Many elderly people face a myriad of health problems that serves as barriers to food consumption, making a strong case for the need for enteral nutrition. This increase is expected to result in an expansion of the enteral feeding market in the country over the long term.
     
  • Consequently, these factors are anticipated to propel market growth in the U.S. in the coming years.
     

From 2024 to 2032, the UK enteral feeding formulas market is poised for notable expansion.
 

  • National Health Service (NHS) in the UK has put more scope on the nutrition care of patients as more important than it used to be. For instance, the British Dietetic Association has published its Nutrition and Hydration Digest for the benefit of all health practitioners. This has led to greater adoption of enteral feeding formulas, which in turn, has led to better patient care.
     
  • The UK has defined strict measures to regulate the quality and safety of enteral feeding systems. For instance, according to the NHS England's operational guidance 2022/23, nutrition and hydration is one of the main issues of concern in the region. Of these regulations, proper patient nutrition while in hospital provides incentives for manufacturers to produce more quality formulas which ultimately improves the lives of patients who rely on enteral nutrition systems.
     
  • Thus, heightened awareness and government initiatives are set to significantly drive market growth in the UK in the coming years.
     

Japan's enteral feeding formulas market is set for considerable growth between 2024 and 2032.
 

  • According to the World Health Organization, in 2023, Japanese citizens had one of the highest life expectancies in the world, with women averaging at 87.14 years and men at 81.09 years. This unprecedented number indicated that the population was aging rapidly, with BBC reports stating that 29.1% of citizens were 65 years or older in 2023. The increase in citizens means that as older adults tend to suffer from chronic complications that result in oral difficulties, the need for enteral feeding formulas becomes evident. This growth in demand is likely to keep propelling the growth of enteral feeding market in Japan.
     
  • Strategic management of nutrition is at the heart of the Japanese Health Care System. For example, the Japanese Society of Intensive Care Medicine has produced comprehensive standards of care for nutrition Support Therapy for adult and pediatric patients in critical care.
     
  • There is a developing consensus among health care providers regarding the significance of nutrition in recovery and in enhancing life of a patient with chronic illness. This perception is adding towards increasing need of enteral feeds within Japanese population. As improvements in health care continue, the nutritional needs of the population will also increase, along with the enteral feeding market.
     
  • Given these insights, the factors highlighted are poised to bolster market growth in Japan over the forecast period.
     

Saudi Arabia's enteral feeding formulas market is on track for significant growth from 2024 to 2032.
 

  • In line with its Vision 2030 strategy, the Saudi government is investing heavily in healthcare capital systems. This includes not just the building of more hospitals and healthcare centers, but also the improvement in the availability of enteral feeding products and services. There is an expectation that these activities will increase markedly the need for enteral feeding products in the country.
     
  • A surge is being witnessed in diabetes, obesity, and cancer which hints towards the fact that there is an increase in chronic diseases within Saudi Arabia. The Saudi Ministry of Health reports the country having one of the highest diabetes prevalence rates in the world, which often leads to complications that require enteral nutrition support.
     
  • According to the International Diabetes Federation, in 2021, 17.7% or more than one in six adults in Saudi Arabia were diabetic which is higher than most nations. Because of this high prevalence rate and its associated hindrances, it can be anticipated that there will be an increase in demand for enteral feeding solutions in Saudi Arabia.
     
  • Considering these insights, the factors discussed are anticipated to drive market growth in Saudi Arabia in the coming years.
     

Enteral Feeding Formulas Market Share

The market rests with a mixture of large and small to medium sized businesses from around the world that compete for shares, making the market highly competitive. One key part of the market plan includes the constant development of new products based on different types of technologies. It should be noted that many of these market leaders have an important position at the very top of this industry due to the fact that they tend to invest a lot of money into research and development so they can market new products quickly. Furthermore, mergers, acquisitions, and alliances play an important role in strengthening their position in the competitive market and widening the scope of their business due to changing regulations.
 

USPs for the top market players

  • PediaSure and Ensure lines from Abbott Laboratories are noteworthy for their clinically sophisticated enteral feeding formulas for children and adults, respectively. These products are utilized to deliver adequate nutrition for malnourished or critically ill children and adults, and they are backed by Abbott’s global healthcare infrastructure.
     
  • Patients having issues with digestion are better served by Fresenius Kabi’s Osmolite and Peptamen enteral nutritional products. Their products are made easy to digest and easily absorbed, which certainly sets the practice of nutritional support above the rest.
     
  • As a major supplier of plant-based organic enteral feeding formulas, Kate Farms fills the gap in the market for nutritious, dietary welcomers that are free from allergens and dairy. These have emerged due to an increased requirement from patients that enforce dietary restrictions because of allergies.
     
  • The enteral formulas BOOST and Resource from Nestlé are well known for the specific requirements of patients like athletes and those who need to gain weight or have a lot of fibers in their diets. With the support of advanced R&D of Nestlé Health Science, their products have been proven to deliver the best clinical results wherever they are needed.
     

Enteral Feeding Formulas Market Companies

Some of the eminent market participants operating in the enteral feeding formulas industry include:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International
  • Danone S.A.
  • Fresenius Kabi
  • Functional Formularies
  • Hormel Health Labs
  • Kate Farms
  • Medtrition
  • Meiji Holdings
  • Nestlé
  • NutriMedical
  • Real Food Blends
  • Vegenat Healthcare
  • Victus
     

Enteral Feeding Formulas Industry News

  • In August 2024, Abbott Laboratories announced a partnership with the American Diabetes Association (ADA) aimed towards obtaining greater understanding related to the dietary needs of people suffering from diabetes, obesity, and other metabolic disorders. The goal was to understand the role, if any, of tailored dietary nutrition formulas in meeting the specific and general nutritional needs of these patients.
     
  • In November 2021, Abbott Laboratories announced the launch of Similac 360 Total Care, an innovative infant formula. It was specially designed to match the nutritional profile of human milk during the first 12 months of life. The formula contained Human Milk Oligosaccharides (HMOs), which are some of the important prebiotics also present in breast milk.
     

The enteral feeding formulas market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Market, By Product

  • Standard formulas
  • Disease specific formulas
  • Elemental formulas
  • Semi-elemental formulas
  • Other formulas

Market, By Stage

  • Adults
  • Pediatric

Market, By Application

  • Oncology
  • Gastrointestinal diseases
  • Neurological disorders
  • Diabetes
  • Critical care
  • Other applications

Market, By End Use

  • Hospitals
  • Long term care facilities
  • Home care settings
  • Nursing homes

The above information is provided for the following regions and countries:

  • North America 
    • U.S.
    • Canada 
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Netherlands 
  • Asia Pacific 
    • China
    • Japan
    • India
    • Australia
    • South Korea 
  • Latin America
    • Brazil
    • Mexico
    • Argentina 
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE


 

Authors: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :
Who are some of the prominent players in the enteral feeding formulas industry?
Key players in the industry include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Danone S.A., Fresenius Kabi, Functional Formularies, Hormel Health Labs, Kate Farms, Medtrition, and Meiji Holdings.
Why is the use of standard enteral feeding formulas rising?
What is the size of the U.S. enteral feeding formulas market?
How big is the enteral feeding formulas market?
Enteral Feeding Formulas Market Scope
  • Enteral Feeding Formulas Market Size
  • Enteral Feeding Formulas Market Trends
  • Enteral Feeding Formulas Market Analysis
  • Enteral Feeding Formulas Market Share
Related Reports
    Authors: Mariam Faizullabhoy, Gauri Wani
    Buy Now
    $4,123 $4,850
    15% off
    $4,840 $6,050
    20% off
    $5,845 $8,350
    30% off
        Buy now
    Premium Report Details

    Base Year: 2023

    Companies covered: 15

    Tables & Figures: 185

    Countries covered: 19

    Pages: 150

    Download Free PDF

    Top